The race for vaccination against covid-19 has caused a rather peculiar situation.
Almost a year after the World Health Organization (WHO) started talking about a pandemic and with several vaccines from different laboratories approved and available to the public in several countries, one question sums up a new concern: Which vaccine is better?
John Wright, who is a physician at Bradford Royal Infirmary University Hospital in central England, realized that his medical colleagues prefer one vaccine, while the public often opts for another.
“Now we have a variety of vaccines and people are beginning to ask me if they can choose or which vaccine I would recommend,” he tells the BBC.
For him, it is not a time to choose.
Concern about the selection of the covid-19 vaccine is a recurring theme in several countries where vaccination has been implemented.
For example, that is the case of the main Italian teachers union that rejects the AstraZeneca vaccine because it believes that those produced by Pfizer and Moderna are more effective.
This rejection is also observed in various sectors of the population in Europe after the authorities of Norway, Denmark, Iceland, the Netherlands, France, Germany and Belgium, among others, reported that they will not apply this vaccine to people over 65 years of age because they consider that there is insufficient data on its effectiveness.
However, on February 16, two versions of the AstraZeneca / Oxford vaccine against covid-19 were included in the WHO list for use in emergencies.